DrugPatentWatch Database Preview
CLINICAL TRIALS PROFILE FOR CEFPROZIL
Clinical Trials for Cefprozil
Trial ID | Title | Status | Sponsor | Phase | Summary |
---|---|---|---|---|---|
NCT00778245 | Bioequivalence Study of Cefprozil Tablets, USP 500 mg Undef Fed Conditions | Completed | Ranbaxy Laboratories Limited | N/A | The objective of this study is to assess the single - dose relative bioavailability of Ranbaxy and Bristol-Myers Squibb Company (CEFZIL ®) 500 mg cefprozil tablets, under fed conditions. |
NCT00778557 | Bioequivalence Study of Cefprozil 250 mg/ 5mL Powder For Oral Suspension Under Fasting Conditions | Completed | Ranbaxy Laboratories Limited | N/A | The study was conducted as a blinded, randomized, 3-way crossover study to compare the single-dose relative bioavailability of Cefprozil 250 mg/5 mL Oral suspension versus Cefzil TM Powder for Oral Suspension (250 mg/5 mL) following one 5 mL dose under fasting conditions |
NCT00778739 | Bioequivalence Study of Cefprozil 250 mg/ 5mL Powder For Oral Suspension Under Fed Conditions | Completed | Ranbaxy Laboratories Limited | N/A | The study was conducted as an open-label, randomized, 2-way crossover study to compare the single-dose relative bioavailability of Cefprozil 250 mg/5 mL Oral suspension versus Cefzil TM Powder for Oral Suspension (250 mg/5 mL) following one 5 mL dose under fed conditions |
NCT00778778 | Bioequivalence Study of Cefprozil Tablets, USP 500 mg Under Fasting Conditions | Completed | Ranbaxy Laboratories Limited | N/A | The objective of this study was to assess the single-dose relative bioavailability of Ranbaxy and Bristol-Myers Squibb Company (CEFZIL ®) 500 mg cefprozil tablets, under fasting conditions. |
Trial ID | Title | Status | Sponsor | Phase | Summary |
Clinical Trial Conditions for Cefprozil
Condition Name
Clinical Trial Locations for Cefprozil
Trials by Country
Clinical Trial Progress for Cefprozil
Clinical Trial Phase
Clinical Trial Sponsors for Cefprozil
Sponsor Name